FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#3 | ||
|
|||
Magnate
|
--that similar initiatives in the past have not panned out--and WinSanTor has not exactly reached out to the neuropathy community; they seem to be more entrepreneurially based.
Nevertheless, I sent this quickie email to them. As a long time neuropathy health activist and Board Member/Secretary of the Western Neuropathy Association, I try to keep up on developments in the field, so of course I have been watching WinSanTor with interest. I would love to talk with your and exchange notes at some point; insamuch as there is yet no direct rehabilitative treatment for neuropathy, obviously a lot of us are hoping that your clinical trials pan out. Moreover, I don't know if you've noticed it or not, but what you are involved in has not gotten much publicity in the neuropathy community (I realize it may be early); still, it might behoove you all to reach out and have more contacts in that community. --Glenn Ribotsky Secretary Western Neuropathy Association |
||
![]() |
![]() |
Thread Tools | |
Display Modes | |
|
|
![]() |
||||
Thread | Forum | |||
23andMe - Update On The Regulatory Review Process With The FDA | Parkinson's Disease | |||
Update on my process / healing | Traumatic Brain Injury and Post Concussion Syndrome | |||
Miami Event: Research Update & Biomarker Discussion - Monday, January 30th, 4:30pm | Parkinson's Disease | |||
FDA To Strengthen Generic Drug Program...Streamline Generic Drug Approval Process | Parkinson's Disease | |||
The Problem with the FDA Drug Approval Process | ALS News & Research |